Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: Clinical outcome and pathologic correlation

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 895-900

  Katz, Alan W ^a   Chawla, Sheema ^a   Qu, Zhenhong ^b   Kashyap, Randeep ^a   Milano, Michael T ^a   Hezel, Aram F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Hepatocellular carcinoma; Stereotactic hypofractionated radiation therapy; Transplant

Indexed keywords

CLINICAL OUTCOME; COMPUTED TOMOGRAPHY; GASTROINTESTINAL TOXICITIES; HEPATOCELLULAR CARCINOMA; IN-FIELD; LIVER TRANSPLANTATION; MORPHOMETRIC METHOD; PATHOLOGICAL RESPONSE; RADIATION-INDUCED LIVER DISEASE; RADIO-FREQUENCY ABLATION; SIDE EFFECT; TOTAL DOSE; TUMOR NECROSIS;

COMPUTERIZED TOMOGRAPHY; POLYMETHYL METHACRYLATES; TRANSPLANTS; TUMORS;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; STEREOTACTIC HYPERFRACTIONATED RADIATION THERAPY; STEREOTACTIC PROCEDURE; TUMOR NECROSIS;

AGED; CARCINOMA, HEPATOCELLULAR; DOSE FRACTIONATION; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NECROSIS; ORGAN SIZE; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN; WAITING LISTS;

EID: 84861620356     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.032     Document Type: Article

References (25)

1. D.M. Parkin, F. Bray, and J. Ferlay Estimating the world cancer burden: GLOBOCAN 2000 Int J Cancer 94 2001 153 156
2. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
3. A. Jemal, R. Siegel, and J. Xu Cancer Statistics, 2010 CA Cancer J Clin 60 2010 277 300
4. M. Schwartz Liver transplantation in patients with hepatocellular carcinoma Liver Transpl 10 Suppl 1 2004 S81 S85
5. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
6. J.M. Llovet, J. Bruix, and G.J. Gores Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy Hepatology 31 2000 1019 1021
7. F.Y. Yao, R. Hirose, and J.M. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514
8. D.S. Lu, N.C. Yu, and S.S. Raman Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation Hepatology 41 2005 1130 1137
9. J.T. Heckman, M.B. Devera, and J.W. Marsh Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation Ann Surg Oncol 15 2008 3169 3177
10. L.M. Kulik, B. Atassi, and L. van Holsbeeck Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellularcarcinoma: Downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586
11. P.E. Majno, R. Adam, and H. Bismuth Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
12. T.S. Lawrence, J.M. Robertson, and M.S. Anscher Hepatic toxicity resulting from cancer treatment Int J Radiat Oncol Biol Phys 31 1995 1237 1248
13. T.S. Lawrence, R.K. Ten Haken, and M.L. Kessler The use of 3-D dose volume analysis to predict radiation hepatitis Int J Radiat Oncol Biol Phys 23 1992 781 788
14. S.X. Liang, X.D. Zhu, and Z.Y. Xu Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation tolerance Int J Radiat Oncol Biol Phys 65 2006 426 434
15. M. Sato, M. Uematsu, and F. Yamamoto Feasibility of frameless stereotactic high dose radiation therapy for primary or metastatic liver cancer J Radiosurg 1 1998 233 238
16. A.W. Katz, M. Carey-Sampson, and A.G. Muhs Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases Int J Radiat Oncol Biol Phys 67 2007 793 798
17. J. Bruix, M. Sherman Practice Guidelines Committee for the American Association for the Study of Liver Diseases Management of hepatocellular carcinoma Hepatology 42 2005 1209 1236
18. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
19. R.A. Fisher, D. Maluf, and A.H. Cotterell Non-resective ablation therapy for hepatocellular carcinoma: Effectiveness measured by intention-to-treat and dropout from liver transplant waiting list Clin Transplant 18 2004 502 512
20. G. Millonig, I.W. Graziadei, and M.C. Freund Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl 13 2007 272 279
21. A.A. Al Hamad, M. Hassanain, and R.P. Michel Stereotactic radiotherapy of the liver: A bridge to transplantation Technol Cancer Res Treat 8 2009 401 405
22. J.K. O'Connor, R.M. Goldstein, and B.D. Berger Stereotactic body radiation therapy as a bridge to transplant in hepatocellular carcinoma: Acute toxicity and explant pathology. Abstract 1034 Int J Radiat Oncol Biol Phys 72 Suppl 1 2008 S128
23. C. Sandroussi, L.A. Dawson, and M. Lee Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma Transpl Int 23 2010 299 306
24. D.L. Andolino, M. Maluccio, and C. Calley Stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC): The Indiana University experience Int J Radiat Oncol Biol Phys 78 Suppl 3 2010 S74
25. B.O. Choi, H.S. Jang, and K.M. Kang Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma Jpn J Clin Oncol 36 2006 154 158